Bicalutamide,Goserelin acetate,Leuprolide acetate
tolmar,sanofi,recordati
[]
 agree with chris and tyler. the evidence is strong for 24 mos. natural conclusion has to be it's the salvage cohort that's benefiting. with dadsport, anxious to see both 1) the salvage only subgroup 6 vs 24 mos and 2) test for interaction with gs in that sub-group.
Chief, Manhattan Service, @MSK_RadOnc; GU and HN cancers; hubs and dad to 3; MD(@YaleMed) MPH (@HarvardSPH) MSL (@NorthwesternMSL) 🏳️‍🌈